Welcome to CDC Stacks | Manual for the surveillance of vaccine-preventable diseases. Chapter 11: Pneumococcal disease - 35644 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Manual for the surveillance of vaccine-preventable diseases. Chapter 11: Pneumococcal disease
  • Published Date:
    Mar 2012
  • Language:
    English
Filetype[PDF - 323.90 KB]


Details:
  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
  • Series:
    Manual for the surveillance of vaccine-preventable diseases ; chapter 11
  • Document Type:
  • Description:
    Chapter 11 of: Manual for the surveillance of vaccine-preventable diseases. 5th edition, 2012.

    Streptococcus pneumoniae (pneumococcus) is a gram-positive bacterium with more than 90 known serotypes. Pneumococcus is spread by airborne droplets and is a leading cause of serious illness, including bacteremia, meningitis, and pneumonia among children and adults worldwide. Although all serotypes may cause serious disease, a relatively limited number of serotypes cause the majority of invasive pneumococcal disease (IPD).

    The Centers for Disease Control and Prevention’s (CDC) Active Bacterial Core Surveillance (ABCs) has tracked IPD in selected regions of the United States since 1994. ABCs data indicate that individuals aged <2 years and ≥65 years have the highest rates of invasive disease (Table 1). Approximately 10% of all patients with invasive pneumococcal disease die of their illness, but case-fatality rates are higher for the elderly and patients with certain underlying illnesses.

    chpt11-pneumo.pdf

  • Supporting Files:
    No Additional Files